NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of
USANA Health Sciences, Inc. securities (NYSE:USNA) from March 14, 2014
through February 7, 2017, inclusive (the “Class Period”) of the
important April 14, 2017 lead plaintiff deadline in the class action.
The lawsuit seeks to recover damages for USANA investors under the
federal securities laws.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU
MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU
MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period Defendants made
false and/or misleading statements and/or failed to disclose that: (1)
USANA’s BabyCare subsidiary had engaged in improper reimbursement
practices in China; (2) these practices constituted violations of the
Foreign Corrupt Practices Act; (3) as such, USANA’s China revenues were
in part the product of unlawful conduct and unlikely to be sustainable;
(4) the foregoing conduct, when it became known, was likely to subject
USANA to significant regulatory scrutiny; and (5) as a result, USANA’s
public statements were materially false and misleading at all relevant
times. When the true details entered the market, the lawsuit claims that
investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as
lead plaintiff, you must move the Court no later than April 14, 2017. A
lead plaintiff is a representative party acting on behalf of other class
members in directing the litigation. If you wish to join the litigation,
go to http://rosenlegal.com/cases-1053.html
or to discuss your rights or interests regarding this class action,
please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm
toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com
or kchan@rosenlegal.com.